ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag grant review neuroscience disease medicine immunology

Capsule Reviews
Bob Grant | Aug 1, 2014 | 3 min read
The Myth of Mirror Neurons, Curious, Shadow Medicine, and Doctored
Week in Review, June 17–21
Jef Akst | Jun 21, 2013 | 4 min read
On the gene patent decision; a high-res human brain model; bats’ influence on moths mating calls; toxicants threaten brain health; platelet-driven immunity
Image of someone scratching their skin.
A Chronic Itch: Burrowing Beneath the Skin
Brian S. Kim, MD | Sep 8, 2023 | 9 min read
We have barely scratched the surface of itch science and what it indicates about our health.
Capsule Reviews
Bob Grant | May 1, 2014 | 3 min read
Madness and Memory, Promoting the Planck Club, The Carnivore Way, and The Tale of the Dueling Neurosurgeons
Do Microbes Trigger Alzheimer’s Disease?
Jill U. Adams | Sep 1, 2017 | 10 min read
The once fringe idea is gaining traction among the scientific community.
3D image of a neuron cell network with a red glow representing inflammation.
New Insight into Brain Inflammation Inspires New Hope for Epilepsy Treatment 
Deanna MacNeil, PhD | Jun 1, 2023 | 2 min read
Clinicians and researchers teamed up to investigate how inappropriate proinflammatory mechanisms contribute to the pathogenesis of drug-refractory epilepsy.
Conceptual image of a person's brain with a cluster of cells inside
Is the Immune System to Blame for Schizophrenia?
Diana Kwon | Apr 18, 2022 | 10+ min read
Several lines of evidence suggest that targeting the body’s defense pathways might help treat a subset of people with the psychiatric disorder. But many open questions remain.
Week in Review: October 24–28
Bob Grant | Oct 27, 2016 | 2 min read
Patient Zero exonerated; Jack Woodall dies; Wolbachia-harboring mosquitoes deployed in fight against Zika; implanted neurons function in adult mouse brain 
Updated
blue and white sign for the entrance to the FDA that says U.S. Department of Health and Human Services Food and Drug Administration
Biogen’s Alzheimer’s Drug Gets FDA Approval, Mixed Reviews
Kerry Grens | Jun 7, 2021 | 2 min read
A lackluster performance in clinical trials of the monoclonal antibody aducanumab has left some experts unconvinced of its benefit.

Run a Search

ADVERTISEMENT